Ganciclovir–tenofovir interaction leading to tenofovir‑induced nephrotoxicity
Radhika Soanker1★, Shobha Jagdish Chandra Udutha1, Malladi V S Subbalaxmi2, YSN Raju2★ Corresponding author
- 1Departments of Clinical Pharmacology and Therapeutics, Institute of Medical Sciences, Hyderabad, Telangana, India.
- 2General Medicine, Nizam’s Institute of Medical Sciences, Hyderabad, Telangana, India.
CORRESPONDENCE
Radhika Soanker
Departments of Clinical Pharmacology and Therapeutics, Institute of Medical Sciences, Hyderabad, Telangana, India.
Received: 30-12-2013; Revised: 26-03-2014; Accepted: 25-04-2014.
Volume 5, Issue 4 · pp. 265–267 · PUBLISHED 2014 · DOI: 10.4103/0976-500X.142452
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Viral enteritis is an important gastrointestinal disorder in human immunodeficiency virus (HIV)‑infected patients. Cytomegalovirus (CMV) is the most common opportunistic agent in these patients. As ganciclovir and tenofovir are the most commonly used drugs for the treatment of CMV and HIV infection, respectively, this case report showcases the potentiality of drug interaction as well as the safety measures to be taken when using these two drugs together in unavoidable situations.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Soanker, R., Udutha, S. J. C., Subbalaxmi, M. V. S., & Raju, Y. (2014). Ganciclovir–tenofovir interaction leading to tenofovir‑induced nephrotoxicity. Journal of Pharmacology and Pharmacotherapeutics, 5(4), 265–267. https://doi.org/10.4103/0976-500X.142452
